These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22699458)

  • 41. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
    Sommer A; Winner B; Prots I
    Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of T cells in the pathogenesis of Parkinson's disease.
    Chen Z; Chen S; Liu J
    Prog Neurobiol; 2018 Oct; 169():1-23. PubMed ID: 30114440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
    Appel SH; Beers DR; Henkel JS
    Trends Immunol; 2010 Jan; 31(1):7-17. PubMed ID: 19879804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New Insights into Immune-Mediated Mechanisms in Parkinson's Disease.
    Tan JSY; Chao YX; Rötzschke O; Tan EK
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical characteristics and peripheral T cell subsets in Parkinson's disease patients with constipation.
    Chen Y; Yu M; Liu X; Qu H; Chen Q; Qian W; Wei D; Xu W; Ma B; Wu W
    Int J Clin Exp Pathol; 2015; 8(3):2495-504. PubMed ID: 26045755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of chemokines in Parkinson's disease.
    Liu JQ; Chu SF; Zhou X; Zhang DY; Chen NH
    Brain Res Bull; 2019 Oct; 152():11-18. PubMed ID: 31136787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel immunoregulatory role of perforin-positive dendritic cells.
    Orgad R; Nathansohn-Levi B; Kagan S; Zlotnikov Klionsky Y; Reisner Y
    Semin Immunopathol; 2017 Feb; 39(2):121-133. PubMed ID: 27577575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson's Disease.
    Jiao Z; Zhang W; Chen C; Zhu X; Chen X; Zhou M; Peng G; Liu H; Qiu J; Lin Y; Huang S; Mo M; Yang X; Qu S; Xu P
    ACS Chem Neurosci; 2019 Feb; 10(2):803-811. PubMed ID: 30289236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunology, autoimmunity, and autoantibodies in Parkinson's disease.
    Benkler M; Agmon-Levin N; Hassin-Baer S; Cohen OS; Ortega-Hernandez OD; Levy A; Moscavitch SD; Szyper-Kravitz M; Damianovich M; Blank M; Chapman J; Shoenfeld Y
    Clin Rev Allergy Immunol; 2012 Apr; 42(2):164-71. PubMed ID: 21234712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural Terpenoids as Neuroinflammatory Inhibitors in LPS-stimulated BV-2 Microglia.
    Xu Y; Wei H; Gao J
    Mini Rev Med Chem; 2021; 21(4):520-534. PubMed ID: 31198113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.
    Członkowska A; Kurkowska-Jastrzebska I; Członkowski A; Peter D; Stefano GB
    Med Sci Monit; 2002 Aug; 8(8):RA165-77. PubMed ID: 12165754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease.
    Roussakis AA; Piccini P
    Int Rev Neurobiol; 2018; 141():347-363. PubMed ID: 30314603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice.
    Machado V; Zöller T; Attaai A; Spittau B
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets.
    Kuwana M
    Hum Immunol; 2002 Dec; 63(12):1156-63. PubMed ID: 12480259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.
    Roodveldt C; Labrador-Garrido A; Gonzalez-Rey E; Fernandez-Montesinos R; Caro M; Lachaud CC; Waudby CA; Delgado M; Dobson CM; Pozo D
    PLoS One; 2010 Oct; 5(10):e13481. PubMed ID: 21048992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory dendritic cells in autoimmunity: A comprehensive review.
    Liu J; Cao X
    J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroinflammation and peripheral immune infiltration in Parkinson's disease: an autoimmune hypothesis.
    Monahan AJ; Warren M; Carvey PM
    Cell Transplant; 2008; 17(4):363-72. PubMed ID: 18522239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.